PHARMACEUTICAL PREPARATIONS BE USED

Brand Owner (click to sort) Address Description
ACURA PHARMACEUTICALS Acura Pharmaceuticals, Inc. 616 N. North Court, Suite 120 Palatine IL 60067 Pharmaceutical preparations to be used in opioid-containing pharmaceuticals to minimize the possibility of abuse and addiction to the opioid-containing pharmaceuticals;PHARMACEUTICALS;Pharmaceutical research and development services;
ACURA PHARMACEUTICALS Halsey Drug Co. Inc. 16235 State Road 17 Culver IN 46511 Pharmaceutical preparations to be used in opioid-containing pharmaceuticals to minimize the possibility of abuse and addiction to the opioid-containing pharmaceuticals;PHARMACEUTICALS;Pharmaceutical research and development services;
ILIADIN The Procter & Gamble Company One Procter & Gamble Plaza Cincinati OH 45202 Pharmaceutical preparations to be used in the treatment of acute rhinites, inflammation of the paranasal sinuses, syringites and ottitis media;The wording Iliadin has no meaning in a foreign language.;
ILIADIN MERCK SELBSTMEDIKATION GMBH FRANKFURTER STRASSE 250 DARMSTADT 64293 Germany Pharmaceutical preparations to be used in the treatment of acute rhinites, inflammation of the paranasal sinuses, syringites and ottitis media;The wording Iliadin has no meaning in a foreign language.;
METHIZOLE Merck KGaA, Kommanditgesellschaft auf Aktien Frankfurter Strasse 250 D-64293 Germany Pharmaceutical preparations to be used in the treatment of diseases and disorders of the thyroid gland;
METLIS Merck KGaA, Kommanditgesellschaft auf Aktien Frankfurter Strasse 250 D-64293 Germany Pharmaceutical preparations to be used in the treatment of diseases and disorders of the thyroid gland;
NASIVIN MERCK KGAA Frankfurter Str. 250 64293 Darmstadt F128/002 Germany Pharmaceutical preparations to be used in the treatment of acute rhinitis, inflammation of the paranasal sinues, syringitis and ottitis media;
NASIVIN The Procter & Gamble Company One Procter & Gamble Plaza Cincinati OH 45202 Pharmaceutical preparations to be used for the treatment of acute rhinitis, inflammation of the paranasal sinuses, syringitis and otitis media;
NASIVIN The Procter & Gamble Company One Procter & Gamble Plaza Cincinati OH 45202 Pharmaceutical preparations to be used for the treatment of acute rhinitis, inflammation of the paranasal sinuses, syringitis and otitis media;
NERIXIA ABIOGEN PHARMA S.P.A. Via Meucci, 36 Ospedaletto, Pisa (PI) 56121 Italy Pharmaceutical preparations to be used for the cure and treatment of bone metabolism pathologies;
REPTILASE PENTAPHARM AG DORNACHERSTRASSE 112 AESCH BL 4147 Switzerland Pharmaceutical preparations to be used in the diagnosis of blood coagulation disorders;Color is not claimed as a feature of the mark.;Chemicals for industrial and scientific purposes, namely, laboratory reagents containing an enzyme to be used to test the blood;
THYROCARE Merck KGaA, Kommanditgesellschaft auf Aktien Frankfurter Strasse 250 D-64293 Germany Pharmaceutical preparations to be used in the treatment of diseases and disorders of the thyroid gland;
THYROLINK Merck KGaA, Kommanditgesellschaft auf Aktien Frankfurter Strasse 250 D-64293 Germany Pharmaceutical preparations to be used in the treatment of diseases and disorders of the thyroid gland;
THYROWARE Merck KGaA, Kommanditgesellschaft auf Aktien Frankfurter Strasse 250 D-64293 Germany Pharmaceutical preparations to be used in the treatment of diseases and disorders of the thyroid gland;
THYROZOLE Merck KGaA, Kommanditgesellschaft auf Aktien Frankfurter Strasse 250 D-64293 Germany Pharmaceutical preparations to be used in the treatment of diseases and disorders of the thyroid gland;
 

Where the owner name is not linked, that owner no longer owns the brand

   
Technical Examples
  1. The invention provides compositions, pharmaceutical preparations and methods for inhibition of cystic fibrosis transmembrane conductance regulator protein (CFTR) that are useful for treating secretory diarrhea. The compositions and pharmaceutical preparations of the invention may comprise one or more thiazolidinone compounds, and may additionally comprise one or more pharmaceutically acceptable carriers, excipients, and/or diluents.